Skip to main content
Year archive

AROVELLA THERAPEUTICS LIMITED — 2019 filings

All 74 regulatory filings released by AROVELLA THERAPEUTICS LIMITED (ALA) in 2019, sourced directly from the official regulator.

74 Filings
2019 Period
2019 filings (74)
Filing Released Lang
Australian Public Assessment Report For ArTiMist 2 pages 178.1KB
Regulatory Filings
2019-12-26 English
SANOFI and SUDA Entered Into A Feasibility Agreement 2 pages 181.4KB
Capital/Financing Update
2019-12-08 English
SUDA Signs Co-Development Deal With Ordesa 2 pages 201.9KB
Capital/Financing Update
2019-12-04 English
SUDA Appoints Dr Michael Baker CEO 3 pages 196.9KB
Board/Management Information
2019-11-26 English
Change of Director's Interest Notice 2 pages 280.2KB
Director's Dealing
2019-11-24 English
Completion of Share Consolidation 2 pages 180.9KB
Share Issue/Capital Change
2019-11-21 English
SUDA Receives R&D Tax Incentive Refund 2 pages 122.3KB
Capital/Financing Update
2019-11-17 English
AGM Presentation 20 pages 675.1KB
AGM Information
2019-11-11 English
Results of Meeting 2 pages 103.3KB
Declaration of Voting Results & Voting Rights Announcements
2019-11-11 English
Update - Consolidation/Split - SUD 5 pages 45.0KB
Share Issue/Capital Change
2019-11-11 English
SUDA Management Changes 2 pages 120.1KB
Board/Management Information
2019-11-07 English
Consolidation/Split - SUD 5 pages 44.4KB
Share Issue/Capital Change
2019-11-05 English
Case For Share Consolidation and Appendix 3A.3 11 pages 361.7KB
Share Issue/Capital Change
2019-11-03 English
Appendix 4C - quarterly 7 pages 282.1KB
Interim / Quarterly Report Q1 2020
2019-10-30 English
SUDA Finalises Agreement With Cann Pharmaceutical 3 pages 156.6KB
Capital/Financing Update
2019-10-29 English
Notice of Annual General Meeting/Proxy Form 30 pages 704.0KB
AGM Information
2019-10-13 English
Proposed Share Consolidation 3 pages 127.6KB
Share Issue/Capital Change
2019-10-13 English
ArTiMist Appeal Reasons For Decision 2 pages 119.2KB
Regulatory Filings
2019-10-03 English
Response to ASX Query regarding Accounts 9 pages 735.8KB
Audit Report / Information FY 2019
2019-10-01 English
TGA Declines ArTiMist Appeal 1 page 114.7KB
Regulatory Filings
2019-09-30 English
Manaing Director and CEO Resignation 2 pages 126.0KB
Board/Management Information
2019-09-23 English
Final Director's Interest Notice 3 pages 207.8KB
Board/Management Information
2019-09-23 English
Annual Report to shareholders 87 pages 2.8MB
Annual Report FY 2019
2019-09-23 English
Appendix 4G and Corporate Governance Statement 24 pages 506.8KB
Regulatory Filings
2019-09-23 English
Change of Director's Interest Notice 2 pages 200.5KB
Director's Dealing
2019-09-10 English
Preliminary Final Report 12 pages 237.2KB
Annual Report FY 2019
2019-08-29 English
Article on Anagrelide 5 pages 3.5MB
Regulatory Filings
2019-08-28 English
Corporate Presentation 31 pages 2.4MB
Investor Presentation
2019-08-26 English
New Project Director For Anagrelide Project 2 pages 137.3KB
Board/Management Information
2019-08-13 English
ArTiMist Appeal Lodged With TGA 2 pages 136.2KB
Regulatory Filings
2019-08-08 English
Government Initiatives To Boost Medical Marijuana Industry 2 pages 146.1KB
Regulatory Filings
2019-08-06 English
ZolpiMist Clinical Results Published 2 pages 137.9KB
Regulatory Filings
2019-08-05 English
Appendix 4C - quarterly 7 pages 299.4KB
Interim / Quarterly Report Q4 2019
2019-07-30 English
Operational Update 2 pages 130.8KB
Regulatory Filings
2019-07-24 English
European Anagrelide Cancer Patent 2 pages 147.2KB
Capital/Financing Update
2019-07-21 English
ArTiMist Regulatory Update 2 pages 141.6KB
Regulatory Filings
2019-07-17 English
Top 20 Option Holders 4 pages 134.0KB
Major Shareholding Notification
2019-07-09 English
Top 20 securityholders 2 pages 128.5KB
Major Shareholding Notification
2019-07-02 English
Rights Issue and Placement Completed and Appendix 3B 15 pages 489.6KB
Capital/Financing Update
2019-06-27 English
Change of Director's Interest Notice (x2) 6 pages 459.7KB
Director's Dealing
2019-06-27 English
Supplementary Prospectus 9 pages 378.5KB
Capital/Financing Update
2019-06-26 English
Rights Issue Closes Significantly Oversubscribed 2 pages 150.9KB
Capital/Financing Update
2019-06-25 English
SUDA SIgns Binding Term Sheet With Cann Pharmaceutical 2 pages 148.8KB
Capital/Financing Update
2019-06-04 English
Rights Commence Trading 1 page 130.4KB
Capital/Financing Update
2019-06-04 English
Corporate Presentation June 2019 28 pages 2.3MB
Investor Presentation
2019-06-03 English
SUDA Expands Business Development Team 2 pages 134.8KB
Regulatory Filings
2019-06-03 English
Rights Issue To Raise Up To $3.44 Million 3 pages 157.1KB
Capital/Financing Update
2019-06-02 English
Prospectus For Renounceable Pro Rata Offer 45 pages 1.4MB
Capital/Financing Update
2019-06-02 English
Appendix 3B 13 pages 321.1KB
Capital/Financing Update
2019-06-02 English
Letter To Ineligible Shareholders 1 page 374.9KB
Capital/Financing Update
2019-06-02 English
Letter To Eligible Shareholders 3 pages 100.1KB
Capital/Financing Update
2019-06-02 English
Letter To Optionholders 1 page 376.8KB
Capital/Financing Update
2019-06-02 English
SUDA Launches New Website 1 page 102.7KB
Regulatory Filings
2019-05-30 English
Media Article 1 page 100.1KB
Regulatory Filings
2019-05-26 English
Overview of David Phillips 2 pages 112.7KB
Board/Management Information
2019-05-19 English
SUDA Restructures Board 2 pages 105.1KB
Board/Management Information
2019-05-16 English
Initial Director's Interest Notice 2 pages 102.1KB
Director's Dealing
2019-05-16 English
Final Director's Interest Notice 2 pages 125.7KB
Director's Dealing
2019-05-16 English
Paul Hopper Appointed Chairman 2 pages 109.7KB
Board/Management Information
2019-05-14 English
Product Development Market Update 9 pages 317.7KB
Capital/Financing Update
2019-05-12 English
Appendix 4C - quarterly 7 pages 292.0KB
Interim / Quarterly Report Q3 2019
2019-04-29 English
Trading Halt 2 pages 307.7KB
Regulatory Filings
2019-04-17 English
ArTiMist Regulatory Update 2 pages 134.8KB
Regulatory Filings
2019-04-17 English
SUDA Submits MAA For ZolpiMist 2 pages 146.0KB
Regulatory Filings
2019-04-03 English
Initial Director's Interest Notice 2 pages 147.0KB
Director's Dealing
2019-03-27 English
SUDA Appoints David Simmonds To The Board 2 pages 137.9KB
Board/Management Information
2019-03-26 English
Program Update Anagrelide 3 pages 146.6KB
Capital/Financing Update
2019-03-14 English
Top 20 securityholders 2 pages 128.6KB
Major Shareholding Notification
2019-02-28 English
Half Yearly Report and Accounts 22 pages 1.1MB
Interim / Quarterly Report H1 2019
2019-02-27 English
Program Update Anagrelide 5 pages 182.2KB
Capital/Financing Update
2019-02-20 English
SUDA Continues To Expand Patent Coverage 2 pages 155.0KB
Regulatory Filings
2019-02-17 English
Appendix 4C Amended 6 pages 287.6KB
Interim / Quarterly Report Q2 2019
2019-02-03 English
Appendix 3B 12 pages 315.1KB
Capital/Financing Update
2019-02-03 English
Appendix 4C - quarterly 7 pages 293.3KB
Interim / Quarterly Report Q2 2019
2019-01-30 English